QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
NASDAQ:VYGR

Voyager Therapeutics - VYGR Insider Trading & Ownership

$7.26
-0.11 (-1.49%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$7.21
▼
$7.46
50-Day Range
$6.92
▼
$10.78
52-Week Range
$4.61
▼
$10.81
Volume
125,750 shs
Average Volume
428,653 shs
Market Capitalization
$314.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00

Voyager Therapeutics (NASDAQ:VYGR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
22.00%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$41.70 M
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$12.77 M

VYGR Insider Buying and Selling by Quarter

Get VYGR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Voyager Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Voyager Therapeutics Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/20/2023Robert W HessleinVPSell4,410$7.76$34,221.60102,200  
3/20/2023Robin SwartzCOOSell3,654$7.76$28,355.0472,876  
3/20/2023Todd Alfred CarterInsiderSell2,193$7.76$17,017.6865,360  
2/23/2023Neurocrine Biosciences IncMajor ShareholderBuy4,395,588$8.88$39,032,821.448,575,316  
2/17/2023Robert W HessleinVPSell3,297$7.45$24,562.65106,610  
2/17/2023Todd Alfred CarterInsiderSell738$7.45$5,498.1067,553  
2/13/2023Robert W HessleinVPSell2,868$7.67$21,997.56109,907  
2/13/2023Todd Alfred CarterInsiderSell797$7.67$6,112.9934,291  
2/1/2023Rock Ventures Iii L.P. ThirdMajor ShareholderSell128,642$9.32$1,198,943.444,685,291  
1/30/2023Rock Ventures Iii L.P. ThirdMajor ShareholderSell75,000$9.03$677,250.004,998,933  
1/27/2023Rock Ventures Iii L.P. ThirdMajor ShareholderSell50,000$9.02$451,000.005,073,933  
1/25/2023Rock Ventures Iii L.P. ThirdMajor ShareholderSell50,000$9.22$461,000.005,123,933  
1/23/2023Rock Ventures Iii L.P. ThirdMajor ShareholderSell55,000$9.06$498,300.005,273,933  
1/20/2023Rock Ventures Iii L.P. ThirdMajor ShareholderSell100,000$9.15$915,000.005,328,933  
1/17/2023Robert W HessleinVPSell2,188$9.85$21,551.80112,775  
1/17/2023Todd Alfred CarterInsiderSell1,106$9.85$10,894.1035,088  
1/11/2023Ecor1 Capital, LlcMajor ShareholderSell110,000$8.50$935,000.003,851,507  
1/9/2023Ecor1 Capital, LlcMajor ShareholderSell456,000$7.67$3,497,520.004,297,907  
8/24/2022Rock Ventures Iii L.P. ThirdMajor ShareholderSell149,972$6.09$913,329.485,628,933  
8/15/2022Rock Ventures Iii L.P. ThirdMajor ShareholderSell135,808$6.04$820,280.325,907,361  
8/12/2022Rock Ventures Iii L.P. ThirdMajor ShareholderSell348,007$6.12$2,129,802.846,043,169  
7/14/2022Glenn PierceDirectorSell9,512$6.70$63,730.4016,788  
6/23/2022Ecor1 Capital, LlcMajor ShareholderBuy376,000$5.66$2,128,160.004,753,907  
6/21/2022Ecor1 Capital, LlcMajor ShareholderBuy101,400$5.28$535,392.004,377,907  
4/4/2022Robert W HessleinVPSell2,786$8.25$22,984.50114,963  
4/4/2022Robin SwartzCOOSell1,527$8.25$12,597.7552,060  
(Data available from 1/1/2013 forward)












VYGR Insider Trading Activity - Frequently Asked Questions

Who is on Voyager Therapeutics's Insider Roster?

The list of insiders at Voyager Therapeutics includes Allison Dorval, Andre Turenne, Ecor1 Capital, Llc, Glenn Pierce, Julie Burek, Neurocrine Biosciences Inc, Omar Khwaja, Robert W Hesslein, Robin Swartz, Rock Ventures Iii L.P. Third, and Todd Alfred Carter. Learn more on insiders at VYGR.

What percentage of Voyager Therapeutics stock is owned by insiders?

22.00% of Voyager Therapeutics stock is owned by insiders. Learn more on VYGR's insider holdings.

Which Voyager Therapeutics insiders have been buying company stock?

The following insiders have purchased VYGR shares in the last 24 months: Ecor1 Capital, Llc ($2,663,552.00), and Neurocrine Biosciences Inc ($39,032,821.44).

How much insider buying is happening at Voyager Therapeutics?

Insiders have purchased a total of 4,872,988 VYGR shares in the last 24 months for a total of $41,696,373.44 bought.

Which Voyager Therapeutics insiders have been selling company stock?

The following insiders have sold VYGR shares in the last 24 months: Ecor1 Capital, Llc ($4,432,520.00), Glenn Pierce ($63,730.40), Julie Burek ($9,479.19), Robert W Hesslein ($177,321.78), Robin Swartz ($77,536.56), Rock Ventures Iii L.P. Third ($8,064,906.08), and Todd Alfred Carter ($39,522.87).

How much insider selling is happening at Voyager Therapeutics?

Insiders have sold a total of 1,709,453 Voyager Therapeutics shares in the last 24 months for a total of $12,865,016.88 sold.

This page (NASDAQ:VYGR) was last updated on 3/27/2023 by MarketBeat.com Staff